INTRODUCTION
Patients with neoplastic disease frequently have elevated concentration of orosomucoid (al acid glycoprotein) in plasma (1) . We recently developed a method for isolating homogeneous orosomucoid from as little as 3 ml plasma and found that the circulating orosomucoid in patients with advanced cancer usually possesses an abnormal carbohydrate composition (2) .
The present study investigated concentration and composition of orosomucoid in effusions of neoplastic and nonneoplastic etiology. METHODS 57 pleural and 35 peritoneal effusions were studied; etiology was neoplastic in 58 (Table I ). The fluids were anticoagulated by heparin, centrifuged to remove red blood cells, and stored at -20'C within 1 h after paracentesis.
In all cancer cases, histologic diagnosis and metastatic involvement of visceral or parietal pleura or peritoneum were demonstrated at autopsy. Diagnosis of Laennec's cirrhosis was confirmed by needle biopsy or autopsy.
Each effusion was analyzed for total protein concentration (3) and protein electrophoretic pattern (4) . In addition, 1 ml of each effusion was examined by gel filtration in 1 N acetic acid on a 2 X 200-cm column of Sephadex G-75 (5) . Protein content of the effluent was monitored by measuring optical density at 280 nm. Proteins were recovered from effluent by lyophilization. Homogeneous normal human plasma orosomucoid was prepared by purification of commercial human plasma fraction VI (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.) as described elsewhere (2) . Orosomucoid was isolated from effusions by the method previously developed for plasma (2) . To characterize orosomucoid preparations, the following tests were done (2): acrylamide gel electrophoresis at pH 9.0; measurements of amino acid and carbohydrate compositions; immunodiffusion (at pH 7.2) and immunoelectrophoresis (at pH 8.6) against these antisera (Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif., and Behringwerke AG, Marburg-Lahn, W. (3) and orosomucoid (6) . RESULTS Gel filtration chromatography. The elution profile of normal serum (Fig. 1) (12 cirrhotic, 10 congestive heart failure) resembled the normal serum pattern (Fig. 1A and 1B) . In contrast, most neoplastic effusions showed enlargement of peak b (Fig. 1C) Orosomucoid was isolated from 12 nonneoplastic (8 noninflammatory, 4 inflammatory) and 14 neoplastic effusions by the previously described method (2). Immunodiffusion versus specific rabbit antisera showed that the orosomucoid preparations contained no albumin, a-lipoprotein, transferrin, a2-haptoglobin, fibrinogen, yGimmunoglobulin, ,1 C/j81 A-globulin, al-antitrypsin, a-fetoprotein, a2HS glycoprotein, hemopexin, PjC-glycoprotein, P-lipoprotein, Gc globulin, or a2-macroglobulin. The orosomucoid preparations moved as a single component in acrylamide gel electrophoresis at pH 9.0 (Fig. 2) ; they reacted with a single line of precipitation in Ouchterlony immunodiffusion and in immunoelectrophoresis versus antiserum to normal orosomucoid and versus antiserum to normal human serum (Fig. 3 ).
The orosomucoids isolated from both neoplastic and nonneoplastic effusions were indistinguishable from normal human plasma orosomucoid in these electrophoretic and immunologic tests (Figs. 2 and 3). Likewise, in radial immunodiffusion, orosomucoids isolated from nonmalignant effusions and from normal plasma were indistinguishable (Fig. 4) . Each of five neoplastic orosomucoids examined by this technique, however, showed a subnormal slope for the line relating concentration of the glycoprotein to square of diameter of the precipitate area (Fig. 4) . Orosomucoids derived from benign and malignant effusions were also tested in double immunodiffusion and immunoelectrophoresis against an antiserum to orosomucoid with subnormal carbohydrate content isolated from plasma of a patient with acute myelocytic leukemia (case 19, ref. 2) . Results were indistinguishable from those with antiserum to normal human plasma orosomucoid (Fig. 3) .
Yields of orosomucoid averaged 115, 28, and 45 mg/ 100 ml for neoplastic, nonneoplastic noninflammatory, and nonneoplastic inflammatory effusions, respectively (Table I) .
Normally orosomucoid and other plasma glycoproteins are formed exclusively in the liver (8) . In animals with neoplastic disease, however, a portion of the circulating glycoproteins may be synthesized by tumor (9) . In cirrhosis and heart failure, the ratio orosomucoid/ total protein is generally similar in effusion and in plasma (Table I) , as expected if the effusion's proteins are derived from plasma. In cancer patients, this ratio is 1.5-2.6 times higher in effusion than in corresponding plasma (Table I ). This enrichment of the neoplastic effusion with orosomucoid could result if a portion of the effusion's glycoprotein were produced locally by tumor tissue within the involved synovial cavity.
Rovestad, Bartholemew, Cain, McKenzie, and Soule (10) and Spak (11) showed that concentrations of albumin, and aL, a2, and Y-globulins, and ratios (al + a2) globulin/v-globulin, and a-globulin/total protein, tended to be higher in neoplastic than in nonneoplastic, noninflammatory effusions. The data of Table I suggest that concentration of orosomucoid in the effusion or the ratio of orosomucoid/total protein discriminates more effectively between neoplastic and nonneoplastic, noninflammatory effusions than do the indices proposed by ( (12) . The isomeric aspects of effusion orosomucoid were not studied. Orosomucoid isolated from benign effusions was normal in both amino acid and carbohydrate composition. The glycoprotein isolated from 14 malignant effusions also possessed a protein moiety with normal amino acid contents, but in 11 of the 14 preparations, the structure of the carbohydrate side chains was abnormal. The abnormality consisted of subnormal content of sialic acid (11 of 14), hexose (10 of 14) , and hexosamine (3 of 14), or abnormally high content of hexosamine (4 of 14). The wide variations in ratios of the three types of carbohydrate in neoplastic orosomucoid (Table II) (13) . Qualitatively similar changes were previously observed (2) in the orosomucoid that accumulates in these patients' plasma, but the abnormalities in the effusion's glycoprotein tend to be greater. This tendency can be explained by assuming that orosomucoid in both plasma and effusion of patients with advanced neoplastic disease is a mixture of (a) normal glycoprotein produced by liver and (b) abnormal glycoprotein produced by tumor, and that the ratio of (b) to (a) is higher in effusion than in plasma. Since neoplastic effusions are removed in liter quantities from affected patients, and contain high concentrations of orosomucoid with abnormal carbohydrate composition, these fluids will provide a useful source for further investigation of the cancer-related alteration in the glycoprotein's structure.
Because orosomucoid preparations isolated from neoplastic effusions differ from normal in their carbohydrate content, we have concluded that these fluids contain orosomucoid with abnormal carbohydrate side chains. Alternative explanations could be: (a) orosomu- I of precipitin ring in radial immunodiffusion against rabbit antiserum to normal human plasma orosomucoid. Each 'point shows av+SE of four measurements. The nine orosomucoid preparations were derived from the following sources: a. normal human plasma; b. effusion caused by cirrhosis (case 3); c. effusion caused by cirrhosis (case 4); d. effusion caused by heart failure (case 17); e. effusion caused by carcinoma of the lung (case 24); f. effusion caused by lymphoma (case 36); g. effusion caused by carcinoma of the ovary (case 60); h. effusion caused by carcinoma of the breast (case 50); i. effusion caused by carcinoma of the pancreas (case 75). P value was calculated for difference in slope between line "a" and each other line (20) . P was > 0.05 for b, c, d, e, and f. For g, h, and i, P was < 0.05, < 0.02, and < 0.02, respectively. (Fig. 2) . Subnormal carbohydrate content could influence mobility in two ways: reduced complement of negatively charged sialic acid residues will tend to retard migration towards anode, while decreased molecular size will accelerate this movement. In fact' orosomucoids of differing carbohydrate content (Table II) migrated at closely similar rates (Fig. 2) . Possibly, under different conditions of gel concentration and pH, whereby normal orosomucoid is retarded to a greater degree with respect to buffer front, differences in mobility correlated with sialic acid content and molecular weight may be demonstrable. Thus, acrylamide gel electrophoresis at pH 2.7, but not at 8.9, showed nonidentical patterns for plasma orosomucoids with differing carbohydrate composition (2) .
Orosomucoid Content of Effusions
Concentration of orosomucoid, a significant diagnostic feature in examination of effusions (Appendix), can be rapidly measured by radial immunodiffusion. But the structural abnormality of orosomucoid in most malignant effusions reduces its reactivity with antiserum to normal human plasma orosomucoid (Fig. 4) . Therefore values for orosomucoid in these fluids measured by radial immunodiffusion (Table I) , with normal human plasma orosomucoid as standard, are falsely low by 1040%. The extent of this error can be estimated by testing the effusion in radial immunodiffusion at several concentrations, and comparing the slope of the line relating concentration to the square of the diameter of the precipitate area with that of the standard glycoprotein (Fig. 4) .
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The characteristic feature of nmalignant effusions in gel filtration is enlargement of peak b (Fig. 1) . Only about 20% of this increment stems from orosomucoid; the nature of the remainder is unknown. Accumulation of peak b materials may be of clinical significance because one mass unit of this material (mol wt 30,000-50,000) possesses 2-3 times more colloid osmotic activity than a mass unit of plasma proteins (av mol wt about 100, 000). In neoplastic effusions, the area under peak b ranged from I to i that under peak a (Fig. 1) . If mass is proportional to area, the colloid osmotic activity of a unit weight of protein in neoplastic effusions is 50-100% greater than that in benign effusions. Such abnormally high osmotic activity of proteins in neoplastic effusions will accelerate entry of H20 into the involved synovial cavity. Thus, accumulation of peak b material may play a role in the formation of malignant effusions and in their tendency to reaccumulate rapidly after paracentesis.
Carbohydrate-containing proteins and lipids are prominent constituents of cellular plasma membranes and glycocalyces (14, 15) . "Ektobiologic" properties of cells such as contact inhibition, adhesiveness, and "homing" capacity may be determined in part by these carbohydrate-rich molecules (14) (15) (16) . Glycolipids in some neoplastic cells are deficient in carbohydrates, perhaps because of abnormality in activity of glycosyl transferases (17, 18) . Enzymes of this type also participate in biosynthesis of glycoproteins (13) (14) (15) . Circulating glycoproteins, normally produced largely in the liver, may in tumor-bearing animals also be secreted into body fluids by neoplastic cells (8, 9, 19) . These considerations suggest that the accumulation of orosomucoid with abnormal carbohydrate side chains in body fluids of patients with disseminated cancer (ref. 2 and present study) may be related to invasive properties of neoplastic cells in the patients under consideration.
APPENDIX
The utility of the various concentrations or indices for characterizing neoplastic and nonneoplastic noninflammatory effusions can be compared by the multivariate statistical techniques of discriminant analysis (21) . Briefly, discriminant analysis permits the classification of individuals (effusions) into two or more groups (in this case two groups, neoplastic and nonneoplastic noninflammatory) in terms of one or more variables (total protein, albumin, etc.). The purpose of such an analysis is to find a discriminant function: that is, a linear combination of the variables that will maximally differentiate between the two types of effusion. For example, consider the following four variables measured in the units of Table I : Xi = albumin, Xs = f2-globulin, Xs = y-globulin, and x4 = orosomucoid concentration. The statistical problem is to find the linear combination, al xi + at xs + as xs + a4 X;, which produces the "best" discriminant.
The values for al, a2, as, and a4, are estimated from the data; substituting the value of the four original variables (xi, x:, Xi, and x4) for each effusion into this equation then produces a new variable that is a linear combination of the originals. The difference between the average values of this new variable for the nonneoplastic noninflammatory and neoplastic groups will be a maximum, in the sense that no other linear combination of these four variables can produce better separation or discrimination of the two groups. Furthermore, a particular value of the discriminant function can be used as a cut-off point for classifying subsequent effusions. That is, new measurements on an unclassified effusion can be substituted into the discriminant equation and, depending on whether the resulting value is less or greater than the specified cut-off point, the effusion is classified as nonneoplastic noninflammatory or neoplastic. The probability of correct classification may also be computed. All computational aspects of the discriminant analysis of the present data were performed with the aid of the UCLA Biomedical Computer Program BMDO7M (22) . For the present data, the linear discriminant for the four variables mentioned above is 0.65xi + 7.43xs -5.00x5+ 0.06x4. The correctness of classification of effusions by this equation can be conveniently summarized in Table III . In this case, 50 of the 56 neoplastic effusions were correctly classified by the linear discriminant; all 22 of the nonneoplastic noninflammatory effusions were correctly classified. (Note: Only 78 patients were used in this analysis; two patients were excluded because of missing observations on one of the variables.) In fact, among the seven variables (total protein, albumin, a,, a2, A, and av-globulins, and orosomucoid) that could be included in a discriminant analysis, the four (albumin, at; and 'v-globulins, and orosomucoid) used in the above example provide the best discriminant function based on a stepwise procedure (22) . No further improvement in discrimination can be achieved by adding cl and O-globulins or total protein to the discriminant analysis. The ability of individual variables, or of selected ratios of variables, to discriminate between the two types of, effusion can also be examined in the above fashion. In such cases. the statistical problem is simplified, in that classification is based on the means of the single variable for each group. A particular observation is classified according to its "closeness" to one or the other group mean after appropriate standardization of the scale of measurement. Each of the seven individual variables and, in addition, the ratios (al + a2)/'Y-globulin, 'v-globulin/total protein, and orosomucoid/total protein were examined in this fashion. The correctness of classification for each of these 10 possibilities is summarized in Table IV. Clearly, variable 9, orosomucoid concentration, is the best single variable among the first 10 possibilities for classifying effusions into nonneoplastic noninflammatory and neoplastic categories; 48 of the 56 neoplastic effusions and all 22 nonneoplastic noninflammatory effusions were correctly classified by this variable alone. The linear discriminant with four variables (column 11) did only slightly better. The ratio of (al + a2)/y-globulin (variable 7) correctly classified 49 of 56 neoplastic effusions and 21 of 22 benign noninflammatory effusions. In decreasing order of discriminatory value, the ratios 'v-globulin/total protein and orosomucoid/total protein were next, with each correctly classifying 61 of the 78 effusions, followed by a2-globulin alone (57 of 78 correct) and ending with P-globulin alone (42 of 78 correct). The other variables or ratios were intermediate in their discriminatory value.
Hence, from the perspective of discriminant analysis, orosomucoid concentration stands out as a particularly useful measurement for discriminating between neoplastic and benign noninflammatory effusions. Very little improvement in discrimination was achieved by adding other variables to a discriminant function.
